Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dasatinib induces a response in chronic lymphocytic leukemia.

× No keyword cloud information.

5 in total

Review 1. Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia.

Authors: Kumudha Balakrishnan; Varsha Gandhi
Journal: Expert Opin Investig Drugs Date: 2012-03-09 Impact factor: 6.206

2. Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia.

Authors: Philip C Amrein; Eyal C Attar; Tak Takvorian; Ephraim P Hochberg; Karen K Ballen; Kathleen M Leahy; David C Fisher; Ann S Lacasce; Eric D Jacobsen; Philippe Armand; Robert P Hasserjian; Lillian Werner; Donna Neuberg; Jennifer R Brown
Journal: Clin Cancer Res Date: 2011-03-14 Impact factor: 12.531

3. Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro.

Authors: Lilian Amrein; Lawrence Panasci; Spencer B Gibson; James B Johnston; Denis Soulières; Raquel Aloyz
Journal: Br J Haematol Date: 2009-09-02 Impact factor: 6.998

4. In vivo, ex vivo and in vitro dasatinib activity in chronic lymphocytic leukemia.

Authors: Krzysztof Giannopoulos; Agnieszka Karczmarczyk; Marta Karp; Agnieszka Bojarska-Junak; Kamila Kosior; Małgorzata Kowal; Waldemar Tomczak; Marek Hus; Marcin Machnicki; Tomasz Stokłosa
Journal: Oncol Lett Date: 2021-02-12 Impact factor: 2.967

5. Gene Expression Profiling Predicts Sensitivity of Chronic Lymphocytic Leukemia Cells to Dasatinib.

Authors: Tamara J Blätte; Marcin M Machnicki; Eliza Glodkowska-Mrowka; Anna Dolnik; Marta Karp; Agnieszka Karczmarczyk; Krzysztof Giannopoulos; Lars Bullinger; Tomasz Stoklosa
Journal: Hemasphere Date: 2020-12-16

5 in total